Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Impact of Anaesthesia on Inflammation and NETosis in Hepatocellular Carcinoma Resection
NCT07657897Recruiting
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Nov 2024
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in hepatocellular carcinoma (HCC) (2 arms), sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Primary endpoint: Serum Citrullinated Histone H3 Concentration at 24 hours. Started Nov 2024; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT07657897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07657897.